CompletedPhase 4

Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins

Germany200 participantsStarted 2003-01

Plain-language summary

This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with indication of topical treatment for inflammatory, painful superficial thrombophlebitis of the upper limb * Spontaneous or iatrogenic superficial thrombophebitis of the upper limb Exclusion Criteria: * Hypersensitivity to the study drug, to actylsalicyclic acid and other non-steroidal antirheumatic agents and to the ingredients of the gel * Paitents who had developed asthma, skin reactions or acute rhinitis to acetylsalicylic acid or other non-steroidal antirheumatic agents in the past * Therapy with varicose vein remedies, antithrombotic or antiphlogistic agents as well as corticosteroids for more than 7 days prior to study start * Acute deep vein thrombosis and thrombophlebitis extending into other deep veins Other protocol-defined exclusion criteria may apply

What they're measuring

The area under the curve (AUC) of the symptom score (pain, temperature and size of erythema along the superficial vein)

Trial details

NCT IDNCT00377806

SponsorNovartis

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Superficial Thrombophlebitis of the Upper Limb trials